Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma.
about
Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic reviewManagement Strategies in Advanced Uterine Leiomyosarcoma: Focus on TrabectedinTrabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma.A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the Mayo phase 2 consortium (P2C).Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials.Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin.A review of treatment of uterine leiomyosarcomas.
P2860
Q26822530-6B028EBC-7FC1-490C-B3DD-8EBC9D58F73EQ28087771-D504A88E-11B2-42DB-9EE2-77E322A1CC6FQ34622323-8DA8E415-6874-4E6E-B59E-2548131E6E7FQ35854468-9DF800A3-FC94-4DCE-ACB9-71EFB18B79ABQ37214309-0135DDDD-0801-47D4-B2D3-05688D8F7B1CQ37388663-3F9D1EF0-CB62-48A2-868A-0F5AC5DE5C35Q38153648-F2C565F2-B378-4507-8547-D885FCC67444
P2860
Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma.
@en
type
label
Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma.
@en
prefLabel
Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma.
@en
P2093
P2860
P356
P1433
P1476
Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma.
@en
P2093
Agnieszka Wozniak
Cristiana Stefan
Herlinde Dumez
Ivo De Wever
Pascal Wolter
Paul Clement
P2860
P304
P356
10.2217/14796694.3.4.381
P407
P577
2007-08-01T00:00:00Z